Literature DB >> 19336489

Patients and the public deserve big changes in evaluation of drugs.

Silvio Garattini1, Iain Chalmers.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19336489     DOI： 10.1136/bmj.b1025

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  18 in total

1.  Effect of safety issues with HIV drugs on the approval process of other drugs in the same class: an analysis of European Public Assessment Reports.

Authors:  Arna H Arnardottir; Flora M Haaijer-Ruskamp; Sabine M J Straus; Pieter A de Graeff; Peter G M Mol
Journal:  Drug Saf       Date:  2011-11-01       Impact factor: 5.606

2.  Risk Management Plans: are they a tool for improving drug safety?

Authors:  Serena Frau; Maria Font Pous; Maria Rosa Luppino; Anita Conforti
Journal:  Eur J Clin Pharmacol       Date:  2010-06-25       Impact factor: 2.953

Review 3.  The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication.

Authors:  Gisela Schott; Henry Pachl; Ulrich Limbach; Ursula Gundert-Remy; Klaus Lieb; Wolf-Dieter Ludwig
Journal:  Dtsch Arztebl Int       Date:  2010-04-30       Impact factor: 5.594

4.  The political and ethical challenge of multi-drug resistant tuberculosis.

Authors:  Chris Degeling; Christopher Mayes; Wendy Lipworth; Ian Kerridge; Ross Upshur
Journal:  J Bioeth Inq       Date:  2015-01-29       Impact factor: 1.352

5.  Comparator bias: why comparisons must address genuine uncertainties.

Authors:  Howard Mann; Benjamin Djulbegovic
Journal:  J R Soc Med       Date:  2013-01       Impact factor: 5.344

Review 6.  Drug development: how academia, industry and authorities interact.

Authors:  Silvio Garattini; Norberto Perico
Journal:  Nat Rev Nephrol       Date:  2014-08-05       Impact factor: 28.314

7.  Public health psychopharmacology: a new research discipline comes of age?

Authors:  C Barbui; G Ostuzzi; B Godman
Journal:  Epidemiol Psychiatr Sci       Date:  2018-02       Impact factor: 6.892

8.  Incorporating evidence-based medicine into resident education: a CORD survey of faculty and resident expectations.

Authors:  Christopher R Carpenter; Bryan G Kane; Merle Carter; Raymond Lucas; Lee G Wilbur; Charles S Graffeo
Journal:  Acad Emerg Med       Date:  2010-10       Impact factor: 3.451

Review 9.  A plea for a more epidemiological and patient-oriented pharmacovigilance.

Authors:  Veronica Scurti; Marilena Romero; Gianni Tognoni
Journal:  Eur J Clin Pharmacol       Date:  2011-07-20       Impact factor: 2.953

10.  A new approach to psychiatric drug approval in Europe.

Authors:  Corrado Barbui; Irene Bighelli
Journal:  PLoS Med       Date:  2013-10-15       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.